The Idiopathic Pulmonary Fibrosis (IPF) Treatment Market has evolved into one of the most critical sectors in the healthcare industry due to the rising prevalence of chronic respiratory diseases and increasing awareness regarding early diagnosis and treatment. IPF is a progressive, irreversible lung disease characterized by scarring (fibrosis) of lung tissue, leading to declining...